6A, B and Datasets S1, S36)
Their mechanisms of action involve specific receptor interactions and intracellular signaling cascades that
Puig M, Shubow S (2025) Immunogenicity of therapeutic peptide products: bridging the gaps regarding the role of product-related risk factors
executive dysfunction, which can include problems with planning, cognitive flexibility, abstract thinking, rule acquisition, initiating appropriate actions and inhibiting inappropriate actions, and selecting relevant sensoiy information, fluctuations in attention and slowed cognitive speed, memory (especially in recalling learned information), visuospatial difficulties e.g
Which has fewer side effects, BPC-157 or GHK-Cu
Journal of Bacteriology, 188 (7), 23552363